Showing 1 - 8 of 8
Persistent link: https://www.econbiz.de/10000821041
Persistent link: https://www.econbiz.de/10000922612
Persistent link: https://www.econbiz.de/10001340283
Persistent link: https://www.econbiz.de/10001133174
During the 1980s the share of prescriptions sold by retail pharmacies that was accounted for by generic products roughly doubled. The price response to generic entry of brand-name products has been a source of controversy. In this paper we estimate models of price responses to generic entry in...
Persistent link: https://www.econbiz.de/10014158702
Empirical studies suggest that entry of generic competitors results in minimal decreases or even increases in brand-name drug prices as well as sharp declines in brand-name advertising. This paper examines circumstances under which this empirical pattern could be observed. The analysis focuses...
Persistent link: https://www.econbiz.de/10013226930
During the 1980s the share of prescriptions sold by retail pharmacies that was accounted for by generic products roughly doubled. The price response to generic entry of brand-name products has been a source of controversy. In this paper we estimate models of price responses to generic entry in...
Persistent link: https://www.econbiz.de/10012473564
Empirical studies suggest that entry of generic competitors results in minimal decreases or even increases in brand-name drug prices as well as sharp declines in brand-name advertising. This paper examines circumstances under which this empirical pattern could be observed. The analysis focuses...
Persistent link: https://www.econbiz.de/10012475193